| Literature DB >> 26317331 |
Lei Wang1, Adrianne Wallace2, Sudhir Raghavan1, Siobhan M Deis3, Mike R Wilson4, Si Yang1, Lisa Polin2,4, Kathryn White2,4, Juiwanna Kushner2,4, Steven Orr2, Christina George2, Carrie O'Connor2, Zhanjun Hou2,4, Shermaine Mitchell-Ryan4, Charles E Dann3, Larry H Matherly2,4,5, Aleem Gangjee1.
Abstract
2-Amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine antifolate thiophene regioisomers of AGF94 (4) with a thienoyl side chain and three-carbon bridge lengths [AGF150 (5) and AGF154 (7)] were synthesized as potential antitumor agents. These analogues inhibited proliferation of Chinese hamster ovary (CHO) sublines expressing folate receptors (FRs) α or β (IC50s < 1 nM) or the proton-coupled folate transporter (PCFT) (IC50 < 7 nM). Compounds 5 and 7 inhibited KB, IGROV1, and SKOV3 human tumor cells at subnanomolar concentrations, reflecting both FRα and PCFT uptake. AGF152 (6) and AGF163 (8), 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine thiophene regioisomers, also inhibited growth of FR-expressing CHO and KB cells. All four analogues inhibited glycinamide ribonucleotide formyltransferase (GARFTase). Crystal structures of human GARFTase complexed with 5 and 7 were reported. In severe combined immunodeficient mice bearing SKOV3 tumors, 7 was efficacious. The selectivity of these compounds for PCFT and for FRα and β over the ubiquitously expressed reduced folate carrier is a paradigm for selective tumor targeting.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26317331 PMCID: PMC4714714 DOI: 10.1021/acs.jmedchem.5b00801
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446